Table 2.
Tier | Inclusion criteria | Type of specimen collection | Patient placement and use of personal protective equipment |
---|---|---|---|
In-patients | |||
1 | Patient with clinical criteria (fever or acute respiratory illness or pneumonia) AND with epidemiological criteria (with travel history to a place with active community transmission of COVID-19 or had close contact with a confirmed case of COVID-19) within 14 days before onset of symptoms | Nasopharyngeal flocked swab (NPFS), or nasopharyngeal aspirate (NPA) [in viral transport medium (VTM)] | AIIR (single room) N95 respirator, eye protection by goggles or face shield, gloves, and isolation gown (AAMI level 1)† |
2 | Irrespective of history of travel, patient with pneumonia requiring ICU care; or occurring in clusters; or who is a health care worker. | NPFS, or NPA in VTM; lower respiratory tract such as sputum, tracheal aspirate (TA) (if intubated), and bronchoalveolar lavage (BAL) (if bronchoscopy) | AIIR (single room as far as possible); otherwise cohort nursing in AIIR |
3 | Any patient with pneumonia other than Tier 2 | NPFS, or NPA in VTM; lower respiratory tract such as sputum, TA (if intubated), and BAL (if bronchoscopy) | Surveillance ward (one metre spacing between patients; increase air change per hour by mobile HEPA filter) |
Outpatients in clinics and AEDs | |||
4‡ | Fever or respiratory symptoms subject to clinical assessment of physician in charge | Patients should be smart enough to understand the technique to collect “Deep Throat Saliva” in early morning for adult and pediatric cases | Hospitalization is not required; patients is called back for admission if the specimen is positive for SARS-CoV-2 |
Note. AAMI, Association for the Advancement of Medical Instrumentation PB70:2003 is to define the liquid barrier performance and classification of protective apparel and drapes intended for use in health care facilities (https://www.fda.gov/medical-devices/personal-protective-equipment-infection-control/medical-gowns); AED, accidental and emergency departments; AIIR, airborne infection isolation room; HEPA, high efficiency particulate air; ICU, intensive care unit.
The evolving criteria of active surveillance was reported.9
AAMI level 1 isolation gown is used when small amounts of fluid exposure is anticipated. AAMI level 3 isolation gown can be considered when splashing is anticipated. Alternatively, a waterproof apron on top of the AAMI level 1 isolation gown is also acceptable (with effect from February 19, 2020, day 51).
The fourth tier enhanced laboratory surveillance was updated since February 20, 2020 (day 52).